Klotho Neurosciences Stock Performance
| KLTO Stock | 0.27 0.01 3.18% |
The company secures a Beta (Market Risk) of 3.26, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Klotho Neurosciences will likely underperform. At this point, Klotho Neurosciences has a negative expected return of -0.85%. Please make sure to verify Klotho Neurosciences' skewness, as well as the relationship between the day median price and relative strength index , to decide if Klotho Neurosciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Klotho Neurosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
1 | Klotho Neurosciences, Inc. Sees Significant Drop in Short Interest | 11/05/2025 |
2 | How institutional buying supports Klotho Neurosciences Inc. Equity Warrant stock - Market Risk Analysis Risk Controlled Swing Alerts - newser.com | 11/13/2025 |
3 | Klotho Neurosciences enters securities purchase agreement - MSN | 12/09/2025 |
4 | Acquisition by El-dada Riad Hussein of 20000 shares of Klotho Neurosciences, at 0.41 subject to Rule 16b-3 | 12/10/2025 |
5 | Klotho Neurosciences to Present at the Biotech Showcase 2026 - Yahoo Finance | 01/08/2026 |
6 | Short Interest in Klotho Neurosciences, Inc. Rises By 94.2 | 01/15/2026 |
7 | Whats the beta of Klotho Neurosciences Inc stock - Weekly Market Report High Return Trade Opportunity Guides - baoquankhu1.vn | 01/27/2026 |
| Begin Period Cash Flow | 2808.00 | |
| Total Cashflows From Investing Activities | -123.5 K | |
| Free Cash Flow | -3.1 M |
Klotho Neurosciences Relative Risk vs. Return Landscape
If you would invest 51.00 in Klotho Neurosciences on November 2, 2025 and sell it today you would lose (23.89) from holding Klotho Neurosciences or give up 46.84% of portfolio value over 90 days. Klotho Neurosciences is currently does not generate positive expected returns and assumes 6.0426% risk (volatility on return distribution) over the 90 days horizon. In different words, 54% of stocks are less volatile than Klotho, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Klotho Neurosciences Target Price Odds to finish over Current Price
The tendency of Klotho Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.27 | 90 days | 0.27 | over 95.55 |
Based on a normal probability distribution, the odds of Klotho Neurosciences to move above the current price in 90 days from now is over 95.55 (This Klotho Neurosciences probability density function shows the probability of Klotho Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.26 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Klotho Neurosciences will likely underperform. Additionally Klotho Neurosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Klotho Neurosciences Price Density |
| Price |
Predictive Modules for Klotho Neurosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Klotho Neurosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Klotho Neurosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Klotho Neurosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Klotho Neurosciences is not an exception. The market had few large corrections towards the Klotho Neurosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Klotho Neurosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Klotho Neurosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.06 | |
β | Beta against Dow Jones | 3.26 | |
σ | Overall volatility | 0.08 | |
Ir | Information ratio | -0.16 |
Klotho Neurosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Klotho Neurosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Klotho Neurosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Klotho Neurosciences generated a negative expected return over the last 90 days | |
| Klotho Neurosciences has high historical volatility and very poor performance | |
| Klotho Neurosciences has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (6.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Klotho Neurosciences generates negative cash flow from operations | |
| Klotho Neurosciences has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Whats the beta of Klotho Neurosciences Inc stock - Weekly Market Report High Return Trade Opportunity Guides - baoquankhu1.vn |
Klotho Neurosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Klotho Stock often depends not only on the future outlook of the current and potential Klotho Neurosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Klotho Neurosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 19.2 M | |
| Cash And Short Term Investments | 63.7 K | |
| Shares Float | 66.2 M |
Klotho Neurosciences Fundamentals Growth
Klotho Stock prices reflect investors' perceptions of the future prospects and financial health of Klotho Neurosciences, and Klotho Neurosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Klotho Stock performance.
| Return On Equity | -1.98 | ||||
| Return On Asset | -0.72 | ||||
| Current Valuation | 21.51 M | ||||
| Shares Outstanding | 72.54 M | ||||
| Price To Book | 2.05 X | ||||
| EBITDA | (5.79 M) | ||||
| Net Income | (6.15 M) | ||||
| Total Debt | 271.75 K | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (2.95 M) | ||||
| Earnings Per Share | (0.30) X | ||||
| Market Capitalization | 20.11 M | ||||
| Total Asset | 2.46 M | ||||
| Retained Earnings | (10.56 M) | ||||
| Working Capital | (1.09 M) | ||||
About Klotho Neurosciences Performance
By examining Klotho Neurosciences' fundamental ratios, stakeholders can obtain critical insights into Klotho Neurosciences' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Klotho Neurosciences is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (44.82) | (47.06) | |
| Return On Capital Employed | (5.27) | (5.00) | |
| Return On Assets | (2.88) | (2.73) | |
| Return On Equity | (5.97) | (5.67) |
Things to note about Klotho Neurosciences performance evaluation
Checking the ongoing alerts about Klotho Neurosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Klotho Neurosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Klotho Neurosciences generated a negative expected return over the last 90 days | |
| Klotho Neurosciences has high historical volatility and very poor performance | |
| Klotho Neurosciences has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (6.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Klotho Neurosciences generates negative cash flow from operations | |
| Klotho Neurosciences has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Whats the beta of Klotho Neurosciences Inc stock - Weekly Market Report High Return Trade Opportunity Guides - baoquankhu1.vn |
- Analyzing Klotho Neurosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Klotho Neurosciences' stock is overvalued or undervalued compared to its peers.
- Examining Klotho Neurosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Klotho Neurosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Klotho Neurosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Klotho Neurosciences' stock. These opinions can provide insight into Klotho Neurosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Klotho Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Will Biotechnology sector continue expanding? Could Klotho diversify its offerings? Factors like these will boost the valuation of Klotho Neurosciences. Expected growth trajectory for Klotho significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Klotho Neurosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Klotho Neurosciences is measured differently than its book value, which is the value of Klotho that is recorded on the company's balance sheet. Investors also form their own opinion of Klotho Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Klotho Neurosciences' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Klotho Neurosciences' market value can be influenced by many factors that don't directly affect Klotho Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Klotho Neurosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Klotho Neurosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Klotho Neurosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.